survival time

Ultimovacs Explores Innovative Approaches to Conclude Phase 2 Cancer Trial Amid Prolonged Anticipation for Survival Data

Ultimovacs, a Norwegian biotech company, is grappling with prolonged delays in obtaining midphase melanoma trial data, prompting the company to ...